Several antigens, such as PSCA, MUC1, claudin, CEA, and carcinoembryonic antigen-related cell adhesion molecule (CEACAM7), have been discovered as potential targets for CAR-T cell treatment in pancreatic cancer [136]. This evidence concerns the gene CEACAM5 and familial pancreatic carcinoma.